This comprehensive study provided critical insights into the cell-type-specific regulatory mechanisms in AD, highlighting genes such as SREBF1, APOE, CLU, and others, thereby offering potential therapeutic targets​. This evidence concerns the gene CLU and Alzheimer disease.